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How the host ‘sees’ pathogens: global gene expression
responses to infection
Ian D Manger and David A Relman
Innate immune responses to pathogens are believed to be
patterned and stereotyped. Adaptive responses display variety
but in relatively few types of products and with limited numbers
of mechanisms. Is this apparent disparity between microbial
pathogen diversity and a restricted set of host responses an
accurate picture of infection or is it the result of a limited
collection of analytic tools? DNA microarray technology permits
one to address simple descriptive questions about global gene
expression inside cells. In particular, it offers an opportunity to
examine the relationship between host and pathogen in much
greater detail than has been possible previously. One can now
ask, firstly, how a host cell or organism ‘sees’ a microbial
pathogen from the viewpoint of gene expression responses
and, secondly, at what level it is able to discriminate between
different agents. Other potential insights to be reaped include
the identification of microbial determinants of the host
response, the temporal features of the ‘conversation’ between
host and pathogen, novel strategies for therapeutic and
prophylactic intervention and prognostic markers of outcome.
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Introduction
The interactions between a host and microbial pathogens
are diverse, choreographed and regulated. At one level, the
features and outcomes of these interactions can be assigned
to broad, generic categories, based on the predominant type
of locally recruited leukocyte or T lymphocyte subset or on
the profile of elicited cytokines. The frequently described
‘acute phase response’ and the recent focus on the recognition of pathogen-associated molecular patterns (e.g.
lipopolysaccharide [LPS] lipid A, lipoteichoic acid, peptidoglycan and bacterial lipopeptides) by the innate immune
system underscore the commonalities of the host response
to microbial pathogens. The molecular description of
microbial pathogenesis likewise reveals a number of common themes that involve families of structurally and
functionally related adherence factors, toxins, secretion systems and regulators of microbial gene expression. On the
other hand, detailed analysis of any specific interactions
between pathogen and host uncovers unique mechanisms
and molecules. Each pathogen evolves its own particular

strategy for manipulation of the host that optimizes microbial survival and transmission. Those that find themselves
in a new host without an opportunity for co-adaptation are
more likely to elicit a more dramatic set of host responses.
Thus, in the context of this discussion, to what degree is
the response of the host to any microbial pathogen stereotyped and limited to certain patterned scripts? Does one
find a greater degree of discrimination by the host if one
looks at these responses in more detail? One can certainly
argue that the selection of time and place during the course
of the interaction affects the picture so obtained and might
reflect in part differences between innate and adaptive
immune responses.
High density DNA microarrays have the potential to offer
an unparalleled view of the transcriptional events that
underlie the host response to microbial pathogens. This
view is but one of several perspectives on this process;
other perspectives would include those that focus upon
global host cellular protein expression [1], the global set of
interactions between cellular proteins, a profile of protein
activation states and spatial arrangement of structural and
signaling molecules within a cell. Currently available
microarray technology can provide a quantitative description of the behavior of tens of thousands of genes and
promises within the near future to encompass the complete transcriptosome of humans and model organisms. To
date, however, few reports of the application of this technology to the exploration of interactions between host and
pathogen have been published. These reports are largely
limited to ‘proof-of-concept’ experiments that catalog
genes whose transcriptional activities vary most widely
under defined conditions. As the technology becomes
more widely available, exploration of the relationships
between individual pathogens and their target cells, of the
development of the proinflammatory response and of cell
recruitment, activation and maturation will enable development of a detailed picture of the transcriptional events
that accompany the innate and adaptive responses.
Computational tools offer new ways to visualize microarraybased data and to reveal possible gene functions and
interactions. They currently provide the capacity to identify
gene expression patterns that reflect common themes as
well as unique features of important human diseases. As
these tools are improved and developed further, we anticipate that the detailed description of the interaction of
infectious agents and a variety of ‘target’ host cells, including immune cells, will have a considerable impact on the
diagnosis and therapy of infectious diseases. In the following brief review, we restrict our comments to the study of
host response to infection using DNA microarrays and not to
the use of microarrays to study global microbial responses.
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The latter field is also evolving quickly through its infancy, as complete genome sequences from a rapidly
increasing list of agents become widely available
(http://www.tigr.org/tdb/mdb/mdb.html) and methods for
efficient generation and comprehensive display of all
microbial ORFs (open reading frames) are quickly developed [2]. A few early papers suggest the significant
potential power of this approach [3,4]. Microbial genome
structural (polymorphism) analysis is another potential
application of microbial microarray-based approaches [5,6].

Microarray techniques
The techniques for fabricating materials and reagents, and
probing and gathering data from oligonucleotide or cDNA
microarrays have been reviewed extensively in the past year
and discussion of these topics lies outside of the scope of this
article. The interested reader should refer to [7–9,10•,11,12]
and references therein for further details. At this early stage
in the evolution of this technology it is difficult to predict
whether one particular format or approach will provide consistent advantages over others. However, the abilities to
examine responses from a large number of genes — including those without a known role in immune response — and
to compare multiple methods for pattern recognition may be
especially important. A disproportionate emphasis has been
placed so far on a small number of genes that are strongly
induced in response to many different inflammatory stimuli,
for example genes that encode the known cytokines.

What happens upon stimulation/infection of
host cells?
At the present time, the majority of examples of DNA microarray application to the study of the immune responses are
limited to manipulated immune cell activation with a variety
of generic stimulants and the exploration of subsequent signaling events. For example, Der et al. [13] stimulated HT1080
fibrosarcoma cells with interferon-α, -β and -γ for six hours
and identified more than 1000 genes (out of more than 6800
studied) whose mRNA expression levels varied after treatment with these agents. Application of simple filters to the
data enabled the authors to obtain a list of 122 genes whose
expression varied most widely. Of these, some 40 genes had
previously been identified as interferon-stimulated genes
(ISGs) whereas the remainder represented novel ISGs. Similar experiments examining responses to IL-4 and IL-2 [14]
and T cell responses to heat shock or phorbol esters [15]
have also been reported. It is important, however, to remember that the magnitude of the expression response may not
be the most useful indicator of biological significance.
Zhu et al. [16•] have reported one of the first analyses of the
interaction of a human pathogen with a host cell using
microarrays. Molecular dissection of the genome of human
cytomegalovirus (CMV) had shown that the virus encodes a
number of putative products that would be predicted to
alter gene expression in primary human foreskin fibroblasts
(HFF) and that the virus is known to perturb the cell cycle.
These investigators catalogued 258 human genes (of a total

of approximately 6600 studied) whose expression levels
varied 4-fold (up or down) early in the virus replication
cycle and for a number of cases verified the measured levels by northern blotting. Only a limited number of
samplings were made (40 minutes, 8 hours and 24 hours
post infection). Nonetheless, the data enabled the authors
to speculate on a number of interesting and previously
unrecognized features of CMV infection, such as the upregulation of the gene encoding the nonclassical class I
molecule, HLA-E, as a means to avoid natural killer (NK)
cell surveillance and the increased expression of cytosolic
phospholipase A2 and cyclooxygenase-2 (COX2) as a
means to increase synthesis of the proinflammatory mediator prostaglandin E2. The latter effect may benefit both
host and virus, since inflammation would both stimulate a
cell-mediated immune response and at the same time
attract a reservoir of monocytic cells that might serve to disseminate the infection. A number of herpesvirus family
members (mouse and human CMVs, as well as the
Kaposi’s-sarcoma-associated herpes virus, HHV-8) have
recently been shown to encode chemokine-like functions
that also appear to promote virus dissemination [17,18].
A poster describing the early events that precede the wanton destruction caused by Ebola virus in human monocytes
was presented by K Anderson et al. (abstract VW8.01, 11th
International Congress of Virology, Sydney, August 9–13,
1999). This virus induces strong and sustained release of a
number of cytokines and chemokines as well as the cellular
inhibitors of apoptosis, cIAP1 and XIAP, and the apoptosis
inducer, TRAIL. Recent evidence suggests that survival of
Ebola infection by both guinea pigs and by humans is
dependent upon the development of a sustained T cell
response that precedes effective humoral responses. The
virus itself appears to interfere with the ability to maintain
T cell responses, inducing massive apoptosis in peripheral
blood leukocytes in nonsurvivors [19,20]. In a related study
reported by Xiang et al. [21], the transcriptional responses
induced upon infection of primary human monocytes with
the Zaire and Reston strains of Ebola were analyzed; striking differences between responses to the two strains that
might underlie the differences in their pathogenicity in
humans were reported. Wallace et al. [22] reported on
experiments designed to investigate the effects of
Helicobacter pylori infection on gastric epithelial cells and
cataloged changes in the transcriptional activity of 260
genes of known and unknown function.

Making sense of the data
These ‘proof-of-concept’ experiments demonstrate many of
the fundamental strengths of the microarray approach and
the some of the extraordinary conceptual challenges posed
by data gathering at this scale. Sherlock (this issue,
pp 201–205) has provided a description of some of the tools
already available for storing and analyzing microarray data.
Many of the presentations at The Microarray Meeting
(Scottsdale, Arizona, September 22–25, 1999) suggest that a
formidable arsenal of mathematical and statistical tools are
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under development. Additional issues already tabled [23] are
the establishment of a public database for warehousing and
integrating array data and the adoption of a minimal standard
for submission that will allow data from many laboratories to
be integrated and incorporated into larger analyses. Bassett
et al. [23] emphasize one of the fundamental assumptions
implicit in array-based expression analysis: “knowledge of
where and when a gene is expressed carries important information about what the gene does”. It follows from this
assumption that a first step in the analysis of array-based data
would be to group together genes whose expression patterns
are similar. Cluster analysis methods [24•,25•] provide the
ability to reveal structure within a mass of array data, grouping both known and unknown genes together in ways that
may suggest coordinate control mechanisms and/or function
in common pathways. These sorts of methods have led to the
classification of cell and tissue types, and the inference of
functional categories [26,27•]. Golub et al. [28•] and Alizadeh
et al. [29•] have recently demonstrated the practical utility of
microarray expression analysis in cancer diagnostics. The
first group identified gene ‘classes’ in acute lymphoblastic
and myeloblastic leukemias that serve as predictors when
screening unknown samples. Further refinement of these
classes enabled discrimination of B cell and T cell leukemias
as well as prediction of new classes. The second group were
able to define and distinguish two types of diffuse large-B-cell
lymphoma with different gene expression features, as well as
different clinical outcomes. It is easy to imagine the utility of
gene classes in predicting disease mechanism or responsiveness to therapy. Many of these same approaches and
principles can be applied to infectious disease and to the
identification of diagnostic signatures, predictors of clinical
course of infection and targets for novel intervention.
The potential power of microarray analysis to reveal mechanisms of microbial pathogenesis through host expression
profiling has been barely touched. A particularly effective
approach would compare the responses induced by sets of
microorganisms that differ in a well-defined manner. For
instance, comparisons of a wild-type strain with isogenic
derivatives, each with well-characterized defects in genes
encoding virulence factors, are likely to generate data that
reveal possible mechanisms of action and are more useful
than comparisons between unrelated strains. Purified virulence factors, microbial cell wall components and genetically
inactivated variants of these are also useful reagents and
would serve to help answer questions regarding sufficiency,
rather than essentiality. The question raised at the beginning of this article concerning possible host discrimination
between pathogens and the identification of diagnostic signatures among host response profiles will require the
examination of a wide variety of naturally occurring strains
and species, and application of two-way clustering across all
genes as well as microbial stimuli. We have begun this kind
of investigation, in collaboration with Pat Brown (Stanford
University, Stanford, CA) and Lou Staudt (National Cancer
Institute, Bethesda, MD), by collecting and analyzing
response profiles obtained from human cells exposed to
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various infectious agents in vitro [30–32]. Figure 1 presents
the type of data obtained from these experiments. These
particular data illustrate the hierarchical clustering of
responsive genes in U937 monocytic cells after exposure to
several members of the same Gram-negative bacterial
genus, multiple strains of the same species and some
Figure 1
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Cluster diagram of U937 monocytic cell expression responses to a variety of bacterial species and strains. Bordetella avium, B. parapertussis,
two strains of B. bronchiseptica, multiple strains of B. pertussis —
including an isogenic pertussis toxin mutant — and B. pertussis LPS
were studied. An 18,432 element human cDNA microarray was
employed. Each column represents a single experiment and each row
a single gene. U937 responses to each stimulus were studied at six
different time points (represented as six columns grouped under each
colored triangle in temporal order). Large groups of genes (A–D) respond
in a similar fashion (induced, red; repressed, green) to many or all stimuli.
Other genes respond in a more discriminating manner. The left-hand
column shows uninfected cells; the right-hand column shows the response of peripheral blood mononuclear cells (PBMC) to B. pertusssis.
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purified exo- and endo-toxins (LPS). A much larger effort
will be necessary before any conclusions can be reached
about the presence of diagnostic signatures in vivo (e.g. in
peripheral blood mononuclear cells), the relative importance
of host-to-host variability and the possible basis for a novel
means of classifying infectious agents of disease.

15. Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW: Parallel
human genome analysis: microarray-based expression monitoring
of 1000 genes. Proc Natl Acad Sci USA 1996, 93:10614-10619.
16. Zhu H, Cong JP, Mamtora G, Gingeras T, Shenk T: Cellular gene
•
expression altered by human cytomegalovirus: global monitoring
with oligonucleotide arrays. Proc Natl Acad Sci USA 1998,
95:14470-14475.
This analysis reveals several insights into CMV pathogenesis.
17.

Conclusions
High density DNA microarray analysis of host gene
expression provides a powerful method of examining
microbial pathogens from a novel perspective. The ability
to survey the responses of a large subset of the host
genome, and to find patterns among the profiles from
many different microorganisms and hosts, allows fundamental questions to be addressed (or re-addressed) about
the basis of pathogen recognition, the features of the interaction between host and pathogen and the mechanisms of
host defense and microbial virulence.
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